BetterLife Pharma Inc. (BETRF) financial statements (2022 and earlier)
Company profile
| Business Address |
1275 WEST 6TH AVENUE VANCOUVER, BC V6H 1A6 |
| State of Incorp. | BC |
| Fiscal Year End | January 31 |
| SIC | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 1/31/2019 | 1/31/2018 | 1/31/2017 | 1/31/2016 | 1/31/2015 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments | 75 | 65 | 112 | 72 | 1 | ||
| Cash and cash equivalents | 75 | 65 | 112 | 72 | 1 | ||
| Prepaid expense | 123 | 85 | 17 | 32 | 0 | ||
| Other undisclosed current assets | 44 | ||||||
| Total current assets: | 242 | 149 | 130 | 103 | 1 | ||
| Noncurrent Assets | |||||||
| Property, plant and equipment | 4 | 0 | |||||
| Intangible assets, net (including goodwill) | 8,350 | 235 | |||||
| Intangible assets, net (excluding goodwill) | 8,350 | 235 | |||||
| Deposits noncurrent assets | 3 | 3 | |||||
| Total noncurrent assets: | 8,354 | 235 | 3 | 3 | 0 | ||
| TOTAL ASSETS: | 8,596 | 384 | 133 | 106 | 1 | ||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Debt | 3,498 | 200 | 275 | ||||
| Derivative instruments and hedges, liabilities | 313 | 15 | |||||
| Due to related parties | 330 | 10 | 23 | 38 | |||
| Other undisclosed current liabilities | 997 | ||||||
| Total current liabilities: | 3,828 | 210 | 1,607 | 38 | 15 | ||
| Noncurrent Liabilities | |||||||
| Other undisclosed liabilities | 1,258 | 219 | 397 | 41 | |||
| Total liabilities: | 5,086 | 429 | 1,607 | 435 | 56 | ||
| Stockholders' equity | |||||||
| Stockholders' equity attributable to parent, including: | 3,510 | (45) | (1,474) | (329) | (55) | ||
| Common stock | 21,340 | 8,264 | 7,328 | 7,054 | 3,471 | ||
| Additional paid in capital | 16,999 | 11,816 | 11,211 | 4,575 | 262 | ||
| Accumulated other comprehensive income | 123 | 594 | 585 | 617 | 225 | ||
| Accumulated deficit | (34,963) | (20,719) | (20,598) | (12,591) | (4,012) | ||
| Other undisclosed stockholders' equity attributable to parent | 10 | 16 | |||||
| Total stockholders' equity: | 3,510 | (45) | (1,474) | (329) | (55) | ||
| TOTAL LIABILITIES AND EQUITY: | 8,596 | 384 | 133 | 106 | 1 | ||
Income statement (P&L) ($ in thousands)
| 1/31/2019 | 1/31/2018 | 1/31/2017 | 1/31/2016 | 1/31/2015 | ||
|---|---|---|---|---|---|---|
| Revenues (Financial Services Revenue) | 247 | |||||
| Cost of revenue (Cost of Goods and Services Sold) | (9) | (303) | (4,119) | (2,268) | (3) | |
| Gross profit: | (9) | (57) | (4,119) | (2,268) | (3) | |
| Operating expenses | (6,844) | (1,049) | (6,024) | (8,593) | (117) | |
| Other undisclosed operating income | 9 | 57 | 4,119 | 2,268 | 3 | |
| Operating loss: | (6,844) | (1,049) | (6,024) | (8,593) | (117) | |
| Interest and debt expense | (391) | (27) | (12) | (65) | ||
| Loss from continuing operations before income taxes: | (7,235) | (1,077) | (6,035) | (8,593) | (182) | |
| Income tax expense (benefit) | (1,383) | (1,208) | 47 | |||
| Loss before gain (loss) on sale of properties: | (7,235) | (1,077) | (7,419) | (9,801) | (136) | |
| Other undisclosed net income (loss) | 980 | 1,614 | (839) | |||
| Net loss: | (7,235) | (1,077) | (6,439) | (8,187) | (975) | |
| Other undisclosed net income (loss) attributable to parent | (1,911) | 955 | 160 | (392) | (154) | |
| Net loss available to common stockholders, diluted: | (9,146) | (121) | (6,278) | (8,578) | (1,129) | |
Comprehensive Income ($ in thousands)
| 1/31/2019 | 1/31/2018 | 1/31/2017 | 1/31/2016 | 1/31/2015 | ||
|---|---|---|---|---|---|---|
| Net loss: | (7,235) | (1,077) | (6,439) | (8,187) | (975) | |
| Comprehensive loss: | (7,235) | (1,077) | (6,439) | (8,187) | (975) | |
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (1,788) | 964 | (56) | |||
| Comprehensive loss, net of tax, attributable to parent: | (9,023) | (112) | (6,439) | (8,242) | (975) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.